about
Postmortem evidence of cerebral inflammation in schizophrenia: a systematic reviewSocial Stress and Psychosis Risk: Common Neurochemical Substrates?Kinetic modeling of the monoamine oxidase B radioligand [¹¹C]SL25.1188 in human brain with high-resolution positron emission tomographyFrom dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis.Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.Image derived input function for [18F]-FEPPA: application to quantify translocator protein (18 kDa) in the human brain.White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's diseaseOn the overlap between apathy and depression in dementia.Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.Imaging changes associated with cognitive abnormalities in Parkinson's diseaseThe fatty acid amide hydrolase C385A variant affects brain binding of the positron emission tomography tracer [11C]CURB.Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA.Neuropsychological correlates of normal variation in emotional response to visual stimuliBlocking of fatty acid amide hydrolase activity with PF-04457845 in human brain: a positron emission tomography study with the novel radioligand [(11)C]CURB.Feasibility study of TSPO quantification with [18F]FEPPA using population-based input functionDopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-+-PHNO.Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive taskMapping human brain fatty acid amide hydrolase activity with PET.Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant.Depression in Alzheimer's disease: phenomenology, clinical correlates and treatment.Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis useAmyloid deposition in semantic dementia: a positron emission tomography study.Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [18F]FEPPA.Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for Psychosis.Mechanisms contributing to cognitive deficits in cannabis users.Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment.Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA.Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder.Human Kinetic Modeling of the 5HT6 PET Radioligand 11C-GSK215083 and Its Utility for Determining Occupancy at Both 5HT6 and 5HT2A Receptors by SB742457 as a Potential Therapeutic Mechanism of Action in Alzheimer Disease.Advances in PET analyses of stress and dopamine.Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB.Side effects profile in humans of (11)C-(+)-PHNO, a dopamine D(2/3) agonist ligand for PET.Specificity of symptoms of depression in Alzheimer disease: a longitudinal analysis.Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA.Whole body biodistribution and radiation dosimetry in humans of a new PET ligand, [(18)F]-FEPPA, to image translocator protein (18 kDa).Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PET.Evaluation of a novel radiotracer for positron emission tomography imaging of reactive oxygen species in the central nervous system.A systematic review of the role of the nociceptin receptor system in stress, cognition, and reward: relevance to schizophrenia.Event-Related Potentials in the Clinical High-Risk (CHR) State for Psychosis: A Systematic Review.
P50
Q28077391-356F9289-FABE-43E2-856F-E636B1926855Q30364687-EA6F14F2-CD30-44C8-9D01-90BE17583386Q33581200-763DB500-5FB1-46B4-9659-70486A1F2A92Q34432432-04062D64-84A9-4C83-B733-85F98F3AC429Q34667721-A10D6060-4989-4022-AAF5-7B0DF437BC9FQ34701163-482B55CA-40C7-48B7-98A3-E6F8892FD4CDQ34789872-B9A2BB8A-6D11-494E-ABFD-CC0A9070B459Q35480779-B879A0B3-E628-4030-AE83-E6C44D868770Q35489501-702E2D56-FE01-4B62-9F21-F715A7B42FDCQ35779298-DCCC5EF8-8AFD-4157-AD8F-3C95F98116F8Q35797763-543241F1-7DD2-489F-8CBC-50090E913355Q35925403-4CE28050-CB0C-4E9F-BBD5-C0DA46FCC0AFQ36008271-0C2D6422-C202-4208-87CB-787790312F79Q36177351-7566002E-0F22-4335-B590-B82587535CD0Q36254356-8542CCD9-3852-4903-860A-03371A323E4AQ36381512-AD790AB2-D583-4339-8682-10F9F2319C69Q36610068-0D165362-3A20-479F-A03B-899330BCCCBAQ36636329-88BF4CD0-A148-4292-981D-0CB021968713Q36655387-10CB7D64-F724-4A82-9C07-923B517ACC52Q36765873-57D383F8-DC17-47E2-A04F-2F0B97103358Q37299913-1BE3B226-35A0-417F-AE1E-9B49B5CC846AQ37705759-D869A077-CBC0-4D94-A55E-E7A119899188Q38396800-A43EEF0A-A61C-470A-8DCA-C897971502E4Q38730353-0D45C4AF-560E-41E8-A4D0-C28989A32E72Q39037300-698C9AF0-6CF3-4BBF-A63F-BBD923072675Q39245794-82210FDA-9DA7-4024-BD5E-E0873503AF59Q39323307-0FB34D41-6948-4E23-9658-C1896AD7CB74Q39409090-22759D81-3778-4C59-BDFD-65838D4FDD6FQ40163732-DF420B9C-D4E0-4B6E-8DFC-0C880456166DQ40526275-E1C1D538-78C9-44C2-A89B-A57113043D3BQ42108302-C78A2D02-F708-4CE1-9B9A-54F6FA9E138BQ42652023-98AEF167-FA20-475A-BEFB-1984F623915FQ43164824-9FA53148-5D50-486B-87AD-EE04166EDBCFQ44793679-7D428FA1-5482-458B-A9A8-47BE5FD4F1CAQ44837532-8D1DF1BE-BBFF-460E-A592-85C03253C655Q44951340-8AFC876E-3A48-4797-B8FB-5422548BFA32Q45110152-05E00A75-3D04-4233-8E2E-3021F3BE06BFQ46334335-0FA72594-5E76-4D76-9B8D-FEF97DE9458BQ47549684-68C90EF2-7DF8-453C-8D14-F76CDEFED3DDQ47550634-FE56E146-2770-4DC5-845C-8675770F38C5
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Romina Mizrahi
@en
Romina Mizrahi
@nl
type
label
Romina Mizrahi
@en
Romina Mizrahi
@nl
prefLabel
Romina Mizrahi
@en
Romina Mizrahi
@nl
P31
P496
0000-0001-6667-7928